1-8 of 8
Jennifer Prescott
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Characteristics, Treatment Patterns, and Outcomes of Patients with Mantle Cell Lymphoma By LOT

Helmneh M. Sineshaw, Claire Bai, Enrico De Nigris, Jennifer Prescott, Uzor C. Ogbu, Christina M. Zettler, Laura L. Fernandes, Ching-Kun Wang
Journal: Blood
Blood (2024) 144 (Supplement 1): 6279.
https://doi.org/10.1182/blood-2024-194230
Published: 2024
Journal Articles

Clinical Outcomes and Adverse Events Among Patients with Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma (CLL/SLL) Initiating First-Line (1L) Ibrutinib: Analysis of Subgroups Receiving Subsequent Second Generation (2G) Bruton Tyrosine Kinase Inhibitors, Non-Bruton Tyrosine Kinase Inhibitor Therapy, or Ibrutinib Retreatment in the US Community Oncology Setting

John M. Burke, Ira Zackon, Brittani Wayne, Yunfei Wang, John Murphy, Jennifer Prescott, Shravanthi Gandra, Siyang Leng, Enrico De Nigris
Journal: Blood
Blood (2024) 144 (Supplement 1): 7811.
https://doi.org/10.1182/blood-2024-203667
Published: 2024
Journal Articles

Real-World Outcomes Among 2L+ Patients with Chronic Lymphocytic Leukemia (CLL) By Line of Therapy (LOT)

Matthew S. Davids, Jacob Ambrose, Enrico De Nigris, Jennifer Prescott, Siyang Leng, Mohammed Z.H. Farooqui, Shravanthi R. Gandra, Christina M. Zettler, Laura L. Fernandes, Ching-Kun Wang, Mazyar Shadman
Journal: Blood
Blood (2023) 142 (Supplement 1): 6536.
https://doi.org/10.1182/blood-2023-178727
Published: 2023
Journal Articles

Prevalence of Resistance-Associated Bruton Tyrosine Kinase (BTK) C481 Mutations By Prior Treatment Status Among Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): A Real-World Observational Study

Jennifer Prescott, Torben Steiniche, Jeanette Bæhr Georgsen, Lene Hyldahl Ebbesen, Jens Kanstrup Kjær, Magdalena Snopekova, Laura H. Lorentsen, Tobias Ramm Eberlein, Robert Schou Pedersen, Mohammed Z.H. Farooqui, Bo Wei, Razvan Cristescu, Nicole Myer, Mette Kehlet, Francesco Annibale d'Amore
Journal: Blood
Blood (2023) 142 (Supplement 1): 4649.
https://doi.org/10.1182/blood-2023-181105
Published: 2023
Journal Articles

Characteristics and Outcomes of Patients Receiving Sequential Bruton's Tyrosine Kinase Inhibitor (BTKi)/B-Cell Lymphoma 2 Inhibitor (BCL2i) for Treatment of Chronic Lymphocytic Leukemia (CLL) in the Real-World (rw) Practice Setting

Matthew S. Davids, Jacob Ambrose, Enrico De Nigris, Jennifer Prescott, Siyang Leng, Mohammed Z.H. Farooqui, Shravanthi R. Gandra, Christina M. Zettler, Laura L. Fernandes, Ching-Kun Wang, Mazyar Shadman
Journal: Blood
Blood (2023) 142 (Supplement 1): 6538.
https://doi.org/10.1182/blood-2023-180060
Published: 2023
Journal Articles

A Structured Literature Review Investigating the Current Treatment Landscape in Patients with Richter's Transformation (2011-2021)

Jennifer Prescott, Prabhakar Pandey, Adam Hall, Jyothsna Nathani, Rishabh Pandey, Katherine Elizabeth Ryland, Monika Raut, Patrick Squires
Journal: Blood
Blood (2022) 140 (Supplement 1): 12418–12420.
https://doi.org/10.1182/blood-2022-162230
Published: 2022
Journal Articles

Assessing the Epidemiology, Treatment Patterns, and Economic Impact of Marginal Zone Lymphoma: A Review of the Literature

Patrick Squires, Priyanka Saini, Prabhakar Pandey, Rishabh Pandey, Adam Hall, Katherine Elizabeth Ryland, Monika Raut, Jennifer Prescott
Journal: Blood
Blood (2022) 140 (Supplement 1): 11987–11989.
https://doi.org/10.1182/blood-2022-160070
Published: 2022
Journal Articles

Early-Stage Unfavorable Hodgkin Lymphoma: Patient Characteristics in Real-World Oncology Data from the United States

Santosh Gautam, Shweta Yeola, Akash Nahar, Eric Sarpong, Jennifer Prescott, Xiaoqin Yang, Helmneh Sineshaw
Journal: Blood
Blood (2022) 140 (Supplement 1): 12026.
https://doi.org/10.1182/blood-2022-157820
Published: 2022